Cargando…
Direct comparison of target-reactivity and cross-reactivity induced by CAR- and BiTE-redirected T cells for the development of antibody-based T-cell therapy
The development of chimeric antigen receptor (CAR) and bispecific T-cell engager (BiTE) has led to the successful application of cancer immunotherapy. The potential reactivity mediated by CAR- and BiTE-redirected T cells needs to be assessed to facilitate the application of these treatment options t...
Autores principales: | Maruta, Masaki, Ochi, Toshiki, Tanimoto, Kazushi, Asai, Hiroaki, Saitou, Takashi, Fujiwara, Hiroshi, Imamura, Takeshi, Takenaka, Katsuto, Yasukawa, Masaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746725/ https://www.ncbi.nlm.nih.gov/pubmed/31527633 http://dx.doi.org/10.1038/s41598-019-49834-2 |
Ejemplares similares
-
A single-chain antibody generation system yielding CAR-T cells with superior antitumor function
por: Ochi, Toshiki, et al.
Publicado: (2021) -
Human herpesvirus 6 infection impairs Toll-like receptor signaling
por: Murakami, Yuichi, et al.
Publicado: (2010) -
Application of Adoptive T-Cell Therapy Using Tumor Antigen-Specific T-Cell Receptor Gene Transfer for the Treatment of Human Leukemia
por: Ochi, Toshiki, et al.
Publicado: (2010) -
Efficacy of B7-H3-Redirected BiTE and CAR-T Immunotherapies Against Extranodal Nasal Natural Killer/T Cell Lymphoma
por: Zheng, Meijun, et al.
Publicado: (2020) -
CAR-T cells and BiTEs in solid tumors: challenges and perspectives
por: Edeline, Julien, et al.
Publicado: (2021)